MDCG Guidance on Content of Clinical Investigation Plan: Benefits and Objectives
The new article describes the way study benefits and objectives should be reflected in a clinical investigation plan.
The new article describes the way study benefits and objectives should be reflected in a clinical investigation plan.
The new article provides additional clarifications regarding study design and data management aspects.
The new article highlights specific aspects of a clinical investigation plan, such as the approach to be followed concerning the deviations or informed consent and how it should be obtained before commencing a study.
The article provides a general overview of a vigilance system applicable to CE-marked medical devices intended to be marketed and used in the EU and also highlights certain specific aspects associated thereto.
The article provides a general overview of the regulatory concepts associated with demonstrating substantial equivalence for specific products intended to be marketed and used in the EU.
The new article provides additional clarifications concerning the content of submissions associated with clinical investigations and modifications to it.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report